Ophthalmic Drugs
Learn to Spot Drug-Seeking Behavior
While somewhat uncommon in an optometric setting, you should be prepared to identify and address patients who are on the hunt for prescription painkillers.
02/15/2014
Doxycycline: Do's and Don'ts
This workhouse antibiotic plays a role in the treatment of several ocular conditions, so it is important to understand its uses and risks.
02/15/2014
A Roundup of Recently Approved Ophthalmic Drugs
Simbrinza, Zioptan, Ilevro, Prolensa, Bepreve--just to name a few. Now that we've had a chance to use them, do they measure up to our initial expectations?
02/15/2014
From Molecule to Medicine Cabinet: A Drug’s Long Journey from Development to Approval
For every 10,000 drug compounds developed, only one will achieve FDA approval. Here’s how it happens.
06/15/2013
Are We Gaining Ground on Ocular Infection?
The newer-generation topical fluoroquinolones are some of the most effective antibiotics we’ve ever seen. But, increased bactericidal resistance remains a concern.
12/17/2012
New Drugs in the Ophthalmic Pipeline
ROCK inhibitors, SEGRA compounds and SIRT proteins might be unfamiliar to you now. But you may soon see them in topical drops.
09/15/2012
Mix It Up: When to Call a Compounding Pharmacist
Most medications that we require are readily available. But when they aren’t, it’s time to get creative.
07/15/2012
Generic vs. Brand Drugs: Which is Better?
The cost savings of generic latanoprost may improve compliance, for example, but does the generic “equivalent” work as well as the brand-name drug?
02/15/2012
Relieve Patients’ Itchy, Irritated Eyes
As primary eye care practitioners, we are fortunate to have many readily available and efficacious options to offer our ocular allergy patients.
04/04/2011
Optometry’s History of Prescribing Meds
03/08/2011
Upcoming Events
2019 Conference Planner
Special Conference: Technologies & Treatments in Eye Care
Job of the Week
